Advertisement

Ir Genes pp 203-207 | Cite as

Two Alpha Chains and Three Beta Chains of Human Ia Antigens

  • Olivera J. Finn
  • Ellen Sung
  • Patricia Jones
  • Ronald Levy
Part of the Experimental Biology and Medicine book series (EBAM, volume 4)

Abstract

Human Ia antigens, structural and serologic analogues of murine Ia antigens, are composed of two polypeptide chains, α (34,000 MW) and β (28,000 MW). Like their murine counterparts, these polymorphic chains transiently associate with a third, invariant chain, Ii (31,000 MW) (1). These readily apparent similarities with the mouse raise questions about the genetic organization of the HLA-D region which codes for human Ia antigens. Its murine analog, the I region in the H-2 complex, is known to contain at least five genes whose products have been characterized either biochemically or serologically. In particular, two distinct populations of murine Ia antigens, I-A and I-E/C, have been analyzed and shown to be coded by two separate I region genes (2). In the past, studies based on family data and serology using conventional alloantisera indicated a considerable molecular diversity of the human Ia antigens. Development of hybridoma technology (3) and monoclonal anti-la antibodies provided specific reagents with which to try to isolate various species of human Ia antigens.

Keywords

Alpha Chain Beta Chain Invariant Chain Homozygous Cell Line Human Genetic Mutant Cell Repository 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Winchester, R.J. and Kunkel, H.G. (1979) Adv. Immunol. 28: 221–293.PubMedCrossRefGoogle Scholar
  2. 2.
    Jones, P.O. (1977) J. Exp. Med. 196: 1261–1279.CrossRefGoogle Scholar
  3. 3.
    Köhler, G. and Milstein, C. (1976) Eur. J. Immunol. 6: 511–519.PubMedCrossRefGoogle Scholar
  4. 4.
    Levy, R., Bergman, Y. and Finn, O.J. (1981) In Vitro 17: 1051–1057.PubMedCrossRefGoogle Scholar
  5. 5.
    Finn, O.J. and Levy, R. (1982) Proc. Natl. Acad. Sci. USA 79: 2658–2662.PubMedCrossRefGoogle Scholar
  6. 6.
    O’Farrell, P.Z., Goodman, H.M. and O’Farrell, P.H. (1977) Cell 12: 1133–1142.PubMedCrossRefGoogle Scholar
  7. 7.
    Lampson, L.A. and Levy, R. (1980) J. Immunol. 125: 203–209.Google Scholar
  8. 8.
    Charron, D.J. and McDevitt, H.O. (1979) Proc. Natl. Acad. Sci. USA 76: 6567–6571.PubMedCrossRefGoogle Scholar
  9. 9.
    Accolla, R.S., Gross, N., Carrel, S. and Corte, G. (1981) Proc. Natl. Acad. Sci. USA 78: 4549–4551.PubMedCrossRefGoogle Scholar
  10. 10.
    Markert, M.L. and Cresswell, P. (1980) Proc. Natl. Acad. Sci. USA 77: 6101–6104.PubMedCrossRefGoogle Scholar
  11. 11.
    Goyert, S.M., Shively, J.E. and Silver, J. (1982) J. Exp. Med, in press.Google Scholar
  12. 12.
    de Kretser, T.A., Crumpton, M.J., Bodmer, J.G. and Bodmer, W.F. (1982) Eur. J. Immunol. 12: 214–221.PubMedCrossRefGoogle Scholar
  13. 13.
    Lee, J.S., Trowsdale, J. and Bodmer, W.F. (1982) Proc. Natl. Acad. Sci. USA 79: 545–549.PubMedCrossRefGoogle Scholar
  14. 14.
    Korman, A.J., Knudsen, P.J., Kaufman, J.F. and Strominger, J.L. (1982) Proc. Natl. Acad. Sci. USA 79: 1844–1848.PubMedCrossRefGoogle Scholar
  15. 15.
    Wiman, K., Larhammer, D., Claesson, L., Gustafsson, K., Schenning, L., Bill, P., Böhme, J., Denaro, M., Dobberstein, B., Hammerling, U., Kuist, S., Servenius, B., Sundelin, J., Peterson, P.W. and Rask, L. (1982) Proc. Natl. Acad. Sci. USA 79: 1703–1707.PubMedCrossRefGoogle Scholar

Copyright information

© The Humana Press Inc. 1983

Authors and Affiliations

  • Olivera J. Finn
    • 1
  • Ellen Sung
    • 2
  • Patricia Jones
    • 2
  • Ronald Levy
    • 1
  1. 1.Department of Medicine, Division of Oncology, and Department of BiologyStanford UniversityStanfordUSA
  2. 2.Department of BiologyStanford UniversityStanfordUSA

Personalised recommendations